This is a $6,797.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The award is for the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S and has a completion date of May 23, 2025. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT Generation V Program, which allows the company...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,881.94 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, which does not have a set-aside designation, is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of RINVOQ ER 15 MG TABLET in quantities of 30. The contract has a ceiling value of $9,641.88 and a period of performance through May 29, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET UU 30S. The contract has a ceiling value of $21,163.23 and an ultimate completion date of March 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,358.07, is for the provision of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,950.46, is for the provision of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of December 27, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the purchase of RINVOQ ER 15 MG Tablets. The order has a firm fixed price of $6,107.22 and an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, with a ceiling value of $23,147.15 and a performance period through May 28, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, with a ceiling value of $31,273.41 and a period of performance through May 22, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a ceiling value of $6,223.32 and a performance period extending to May 13, 2025. The contract is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...